Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 354

1.

Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

Bhonsale A, James CA, Tichnell C, Murray B, Madhavan S, Philips B, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):569-78. doi: 10.1161/CIRCEP.113.000233. Epub 2013 May 13.

2.

Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

te Riele AS, Bhonsale A, James CA, Rastegar N, Murray B, Burt JR, Tichnell C, Madhavan S, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H.

J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9. doi: 10.1016/j.jacc.2012.11.087. Epub 2013 Jun 27.

3.

Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.

Hodgkinson KA, Howes AJ, Boland P, Shen XS, Stuckless S, Young TL, Curtis F, Collier A, Parfrey PS, Connors SP.

Circ Arrhythm Electrophysiol. 2016 Mar;9(3). pii: e003589. doi: 10.1161/CIRCEP.115.003589.

4.

Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.

Protonotarios A, Anastasakis A, Panagiotakos DB, Antoniades L, Syrris P, Vouliotis A, Stefanadis C, Tsatsopoulou A, McKenna WJ, Protonotarios N.

Europace. 2016 Apr;18(4):610-6. doi: 10.1093/europace/euv061. Epub 2015 Mar 29.

PMID:
25825460
5.

Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.

Rigato I, Bauce B, Rampazzo A, Zorzi A, Pilichou K, Mazzotti E, Migliore F, Marra MP, Lorenzon A, De Bortoli M, Calore M, Nava A, Daliento L, Gregori D, Iliceto S, Thiene G, Basso C, Corrado D.

Circ Cardiovasc Genet. 2013 Dec;6(6):533-42. doi: 10.1161/CIRCGENETICS.113.000288. Epub 2013 Sep 26.

6.

Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Migliore F, Zorzi A, Silvano M, Bevilacqua M, Leoni L, Marra MP, Elmaghawry M, Brugnaro L, Dal Lin C, Bauce B, Rigato I, Tarantini G, Basso C, Buja G, Thiene G, Iliceto S, Corrado D.

Circ Arrhythm Electrophysiol. 2013 Feb;6(1):167-76. doi: 10.1161/CIRCEP.111.974881. Epub 2013 Feb 7.

7.

Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.

Wong JA, Duff HJ, Yuen T, Kolman L, Exner DV, Weeks SG, Gerull B.

J Am Heart Assoc. 2014 Dec 11;3(6):e001407. doi: 10.1161/JAHA.114.001407.

8.

Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.

Zorzi A, Rigato I, Pilichou K, Perazzolo Marra M, Migliore F, Mazzotti E, Gregori D, Thiene G, Daliento L, Iliceto S, Rampazzo A, Basso C, Bauce B, Corrado D.

Europace. 2016 Jul;18(7):1086-94. doi: 10.1093/europace/euv205. Epub 2015 Jul 2.

PMID:
26138720
9.

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.

Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI.

Circulation. 2010 Sep 21;122(12):1144-52. doi: 10.1161/CIRCULATIONAHA.109.913871. Epub 2010 Sep 7.

10.
11.
12.

Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.

Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.

J Am Coll Cardiol. 2011 Sep 27;58(14):1485-96. doi: 10.1016/j.jacc.2011.06.043.

13.

Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.

Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN.

Eur Heart J. 2015 Apr 7;36(14):847-55. doi: 10.1093/eurheartj/ehu509. Epub 2015 Jan 23.

PMID:
25616645
14.

Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.

Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H.

Int J Cardiol. 2006 Mar 8;107(3):360-8.

PMID:
16503259
15.

Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.

James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, Tedford RJ, Judge DP, Calkins H.

J Am Coll Cardiol. 2013 Oct 1;62(14):1290-1297. doi: 10.1016/j.jacc.2013.06.033. Epub 2013 Jul 17.

16.

Fragmented QRS complex predicts the arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Canpolat U, Kabakçi G, Aytemir K, Dural M, Sahiner L, Yorgun H, Sunman H, Bariş Kaya E, Tokgözoğlu L, Oto A.

J Cardiovasc Electrophysiol. 2013 Nov;24(11):1260-6. doi: 10.1111/jce.12202. Epub 2013 Jul 11.

PMID:
23845044
17.

Usefulness of electrocardiographic parameters for risk prediction in arrhythmogenic right ventricular dysplasia.

Saguner AM, Ganahl S, Baldinger SH, Kraus A, Medeiros-Domingo A, Nordbeck S, Saguner AR, Mueller-Burri AS, Haegeli LM, Wolber T, Steffel J, Krasniqi N, Delacrétaz E, Lüscher TF, Held L, Brunckhorst CB, Duru F.

Am J Cardiol. 2014 May 15;113(10):1728-34. doi: 10.1016/j.amjcard.2014.02.031. Epub 2014 Mar 2.

PMID:
24792740
18.

Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry.

Choudhary N, Tompkins C, Polonsky B, McNitt S, Calkins H, Mark Estes NA 3rd, Krahn AD, Link MS, Marcus FI, Towbin JA, Zareba W.

J Cardiovasc Electrophysiol. 2016 May;27(5):555-62. doi: 10.1111/jce.12947. Epub 2016 Mar 21.

19.
20.

Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Bourfiss M, Te Riele AS, Mast TP, Cramer MJ, VAN DER Heijden JF, VAN Veen TA, Loh P, Dooijes D, Hauer RN, Velthuis BK.

J Cardiovasc Electrophysiol. 2016 Dec;27(12):1420-1428. doi: 10.1111/jce.13094. Epub 2016 Oct 6.

PMID:
27572111

Supplemental Content

Support Center